Cargando…
A SIX1 degradation inducer blocks excessive proliferation of prostate cancer
Prostate cancer (PC) remains a great medical challenge due to its high incidence and the development of castration resistance in patients treated with androgen deprivation therapy. Deubiquitinases, the enzymes that specifically hydrolyze ubiquitin chains on their substrates, were recently proposed a...
Autores principales: | Liao, Yuning, Sun, Wenshuang, Shao, Zhenlong, Liu, Yuan, Zhong, Xiaoyu, Deng, Yuanfei, Liu, Fang, Huang, Hongbiao, Liu, Jinbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990483/ https://www.ncbi.nlm.nih.gov/pubmed/35414775 http://dx.doi.org/10.7150/ijbs.67873 |
Ejemplares similares
-
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
por: Liu, Yuan, et al.
Publicado: (2021) -
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
por: Liao, Yuning, et al.
Publicado: (2020) -
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells
por: Liao, Yuning, et al.
Publicado: (2021) -
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
por: Liao, Yuning, et al.
Publicado: (2017) -
Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling
por: Tan, Yufan, et al.
Publicado: (2021)